- Marteau P, Rambaud. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Micro-biol Rev 1993; 12: 207-20.
- Huius in't Veld J, Shortt C. Selection criteria for probiotic microorganisms. In: Leeds AR, Rowland IR, eds. Gut ? ora and Health-Past, Present and Future. London: The Royal Society of Medicine Press Ltd, 1996: 19 -26.
- Salminen S, Isolauri E, Salminen E. Clinical uses of probiotic for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 1996; 70: 347-58.
- Charteris WP, Kelly PM, Morelli L, Collins JK. Ingredient selection criteria for probiotic microorganisms in functional dairy foods. Int J Dairy Technol 1998; 51: 123 -36.
- Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK. Probiotics: from myth to reality. Demonstration of functionality on animal models of disease and in human clinical trials. Antonie van Leeuwenhoek 1999; 76: 279-92.
- Klaenhammer TR, Kullen MJ. Selection and design of probi-otics. Int J Food Microbiol 1999; 50: 45-57.
- Morelli L, Klein G, Reuter G. Genetic stability of gram-positive strains: summary of a round table discussion. Microecol Ther 1997; 26: 283-7.
- Morelli L, Vescovo M, Cocconcelli PS, Bottazzi V. Fast and slow milk coagulating variants of L. hel×eticus HLM1. Can J Microbiol 1986; 32: 758-60.
- Fortina MG, Parini C, Manachini PG, Morelli L, Bottazzi V, Concari P. Genotypic and phenotypic correlationships among some strains of Lactobacillus hel×eticus. Biotechnol Lett 1990; 12:765-70.
- Vescovo M, Morelli L, Bottazzi V. Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri. Appl Environ Microbiol 1982; 43: 50-6.
Microbial Ecology in Health and Disease
Volume 14, 2002 - Issue 1